NCT01553500View on ClinicalTrials.gov

Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

December 31, 2013

Conditions
Metabolic SyndromeNon Alcoholic Fatty Liver DiseaseInsulin Resistance
Interventions
DIETARY_SUPPLEMENT

glucomannan

glucomannan is administered at dosage of 5g/day in form of biscuits (6 biscuits/day)

BEHAVIORAL

lifestyle intervention

hypocaloric diet (25-30 Kcal/kg/day) or isocaloric (40-45 Kcal/kg/day) and physical activity

Trial Locations (1)

00165

Bambino Gesù Children's Hospital and Research Institute, Rome

All Listed Sponsors
lead

Bambino Gesù Hospital and Research Institute

OTHER

NCT01553500 - Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter